• Endang Sulistiyowatiningsih Pharmacy Department, Islamic University of Indonesia, Indonesia
  • Mutiara Herawati Pharmacy Department, Islamic University of Indonesia, Indonesia




Adherence, MMAS, Hypertension, Primary health care


Objective: Hypertension today has a remained a focus in developing countries. This study aim was to determine the treatment adherence measured by the 8-item Morisky Medication Adherence Scale (MMAS-8) in hypertensive outpatients.

Methods: A cross-sectional study was carried out with hypertensive patients older than 18 y, treated at eight of the primary health care in Special Region of Yogyakarta through interviews, between January and April 2016. Adherence was determine by MMAS-8 version translated for this study.

Results: The patients consider low adherence (score<6), moderate adherence (score 6–7) and high adherence when they had a score equal to 8 at the MMAS-8. The prevalence of adherence among the 233 patients in primary healthcare showed the majority was lower adherence (57.90%), the moderate adherence (30.25%) and the high adherence (11.82%). The average adherence value acoording to the MMAS-8 was 5.2 (±1.7).

Conclusion: Non-adherence treatments of hypertensive outpatients in primary healthcare was highest through application of MMAS-8 


Download data is not yet available.


V Chobanian, GL Bakris, HR Black. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560–72.

PM Kearney, M Whelton, K Reynolds, Muntner P, Whelton PK. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–23.

World Health Organization (WHO). Adherence to long-term therapies: evidence for action. Geneva (Switzerland); 2003.

J Mant, RJ McManus. Does it matter whether patients take antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens 2006;20:551–3.

T Baune, Y Aljeesh, R Bender. Factors of non-compliance with the therapeutic regimen among hypertensive men and women: a case-control study to investigate risk factors of stroke. Eur J Epidemiol 2005;20:411–9.

E Morisky, A Ang, M Krousel-Wood. Predictive validity of medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10:348-54.

Voils RH, Hoyle CT, Thorpe ML, Maciejewski WS, Yancy Jr. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol 2011;64:250-4.

M Krousel-Wood, T Islam, L Webber, RN Re, D Morisky, P Muntner. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009;15:59–66.

G Pittman, Z Tao, W Chen, GD Stettin. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care 2010;16:568-76.

MR Di Matteo. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 y of research. Med Care 2004;42:200-9.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.

M Krousel-Wood, S Thomasa, P Muntner, D Morisky. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357–62.

J George, YT Phun, MJ Bailey, DC Kong, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother 2004;38:1369-76.



How to Cite

Sulistiyowatiningsih, E., and M. Herawati. “A MULTICENTER STUDY TREATMENT ADHERENCE OF HYPERTENSION FOCUSED ON PRIMARY HEALTH CARE IN INDONESIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 14, Aug. 2017, pp. 24-27, doi:10.22159/ajpcr.2017v10s3.21356.



Original Article(s)